Navigation Links
MacroChem to Present at Equities Magazine Conference December 7, 2007 in New York
Date:12/5/2007

WELLESLEY HILLS, Mass., Dec. 5 /PRNewswire-FirstCall/ -- MacroChem's (OTC Bulletin Board: MACM), (http://www.macrochem.com) President and CEO, Robert DeLuccia, will present at the upcoming Equities Magazine Winter Discovery Day Conference XV at the Princeton Club in New York City on December 7, 2007. Mr. DeLuccia is scheduled to present at 11:30 AM EST.

The Equities Corporate Conference is an all day event featuring special presentations from emerging public company CEOs from a wide range of sectors. The conference provides an opportunity for promising emerging growth companies to connect with the investment community. Interested parties can access a live audio webcast of the Company's presentation, through a link at http://www.equitiesmagazine.com. The presentation will be available for 90 days.

About MacroChem

MacroChem Corporation is a specialty pharmaceutical company that develops and seeks to commercialize pharmaceutical products. Our lead product candidate is EcoNail, a topically applied SEPA-based econazole lacquer for the treatment of onychomycosis, a condition commonly known as nail fungus. We recently acquired exclusive worldwide license rights to pexiganan, a novel topical anti-infective for the treatment of diabetic foot infection, which has already completed two Phase 3 trials. Our other clinical stage product candidate, Opterone(R), is a topically applied SEPA-based testosterone cream designed to treat male hypogonadism. Our pipeline of clinical-stage and early-stage product candidates is based on our SEPA, MacroDerm(TM) and DermaPass(TM) drug delivery technologies. For more information visit our website, http://www.macrochem.com.

About Equities Magazine

EQUITIES magazine is focused on bringing together corporate executives and corporate and instit
'/>"/>

SOURCE MacroChem Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. MacroChem To Participate in PIPEs Conference October 18th and 19th in New York City
2. MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Companys Scientific Advisory Board
3. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
4. Avicena Group to Present at Noble Financial Conference
5. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
6. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
7. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
8. CEL-SCI to Present at the Noble Financial Conference
9. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
10. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
11. Strategic Diagnostics Updates Roth Conference Presentation Time

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/ ...ator in biotechnology for diabetes therapy, and a ...rvices to food, supplement, biotechnology and phar...e previously reported $6.3 million registered dire...70 shares of its common stock and warrants to purc...
(Date:11/19/2009)..., Md., Nov. 19 Spherix I...echnology for diabetes therapy, and a provider of ...od, supplement, biotechnology and pharmaceutical c... Annual Meeting of Shareholders. ,, At the meet... SPEX ) elected the following members to the Boar...
(Date:11/19/2009)...UNSTER, Germany, November 19 MONIT... November 16th, 2009 Flibanserin in the,indication... Parkinson,s,disease for orphan drug status design...evodopa-induced dyskinesia is a complication of th... serious burden to some of those,affected, since i...
(Date:11/19/2009)... Top LASIK surgeons and recognized refractiv...ASIK Surgeons made brought their fellow surgeons u...rection surgery, cataract surgery, and ophthalmolo...cademy of Ophthalmology (AAO) annual meeting in Sa.... Shachar Tauber, Dr. David Huang, MD, Dr. Randy E...
Breaking Biology Technology:Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9
...BRIDGE, Mass., Feb. 6 Idenix,Pharmaceuticals, Inc...agement,will present a corporate overview at the u...February 12, 2008 at 9:30 a.m. ET in the Park Aven...Hotel in New York, NY., The live and archived web...alendar of Events" in the Idenix Investor Center a...
...GARY, Feb. 6 /PRNewswire-FirstCall/ - Dr. Brad Tho.... (TSX: ONC, NASDAQ: ONCY), will,participate as an...itled,"Breaking Down the Barriers to New Neuro-Onc... Conference 2008 on Monday, February 11 at 9:30 a.... more than 1,000,biotechnology and life sciences i...
... Huang named Vice President of Process Development...ce President of Legal Affairs Drs. John Cronan...N CARLOS, Calif., Feb. 6 LS9, Inc., the Renewable...on of two key members of,its executive team: Wei H...f Process Development and Engineering, and Christo...
Other Biology Technology:Media Advisory - Oncolytics Biotech Inc. to Present at Bio CEO & Investor Conference 2LS9, Inc., the Renewable Petroleum Company(TM), Adds Key Positions to Executive Team and Scientific Advisory Board 2
(Date:11/20/2009)...work on many scientific and technological frontier...ovided support that totals nearly $4.3 million for...s under the American Recovery and Reinvestment Act... grants for investigation of solar phenomena. Phil...ill enhance the capabilities of NJIT,s Big Bear So...
(Date:11/20/2009)...niversity of Oklahoma researchers were sequencing ...nome project. Today, the OU Advanced Center for ...nal effort to sequence the tomato genome with a $7...oundation for plant genomics. , "The tomato has...he tomato and crop yields will improve quality of ...
(Date:11/20/2009)...mber 19, 2009 The estimated 4.6 million Americans... developing respiratory symptoms due to poor air q...e study undertaken earlier this year by investigat...inary Medicine. , The studywhich polled more tha...ercent of individuals working in barns complained ...
Breaking Biology News(10 mins):NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2NSF awards $7.5M grant to University of Oklahoma for plant genomics 2Barn personnel experience higher-than-average rates of respiratory symptoms 2When It Comes to Natural Remedies for Hormonal Balance the Proof Is in the Clinical Research 4589 1When It Comes to Natural Remedies for Hormonal Balance the Proof Is in the Clinical Research 4589 2When It Comes to Natural Remedies for Hormonal Balance the Proof Is in the Clinical Research 4589 3For Men Over 50 Odds of Eye Discomfort Increases 48795 1For Men Over 50 Odds of Eye Discomfort Increases 48795 2New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI 28TM 29 for Noninvasive and Continuous Fluid Monitoring 4588 1New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI 28TM 29 for Noninvasive and Continuous Fluid Monitoring 4588 2New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI 28TM 29 for Noninvasive and Continuous Fluid Monitoring 4588 3New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI 28TM 29 for Noninvasive and Continuous Fluid Monitoring 4588 4New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI 28TM 29 for Noninvasive and Continuous Fluid Monitoring 4588 5New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI 28TM 29 for Noninvasive and Continuous Fluid Monitoring 4588 6
...ickel metal hydride (NiMH) technology used for bui...gadgets and now hybrid gas-electric cars believes ...paper published in the current issue of the Inter...d Applications , Stanford Ovshinsky, Chairman and ...ld Hills, Michigan, explains that we already have ...
... treatment of Alzheimer,s disease reports improvem...ed approach. A video accompanying the research, pu...logy, documents rapid language improvement within ...n previous work by the same authors, published in ...his study focuses on the effect of the anti-tumor ...
... gene at a time has earned acceptance in biology l... the technique, called RNA interference, as a tool...ed to humans. , Emory University researchers have...ones can make RNA interference more effective in t...he results will be published online this week in t...
Other Biology News:Closing the hydrogen economic loop 2Class of antibiotics can enhance gene-silencing tool 2
CAOSMC (C354-05) from European Collection of Cell Cultures (ECACC)
CnC (Cn402-05) from European Collection of Cell Cultures (ECACC)
Rabbit Anti-B-FABP (FL-132) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Lambda Protein Phosphatase from New England Biolabs
Biology Products: